Discovery of phosgene and chlorine gas modes of action and therapeutic targets using chemoproteomic profiling strategies
使用化学蛋白质组学分析策略发现光气和氯气的作用模式和治疗靶点
基本信息
- 批准号:10883970
- 负责人:
- 金额:$ 49.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-19 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:Active SitesAcuteAcute Lung InjuryAcylationAffectAnimal ModelAntidotesBinding SitesBiochemicalBioinformaticsBiological MarkersBiologyCell physiologyChemical InjuryChemicalsChlorineCysteineDataDevelopmentEventExposure toFamily suidaeFunctional disorderFutureGasesHydrolysisIndustrializationInhalationLabelLigand BindingLipidsLungMapsMass Spectrum AnalysisMilitary PersonnelModificationMolecularMolecular AnalysisMolecular TargetMusNatureOxidation-ReductionOxidative StressOxidative Stress InductionPathway AnalysisPathway interactionsPhosgenePhysiologyPost-Translational Protein ProcessingPredispositionProtein AnalysisProteinsProteomeProteomicsReactionResearchRoleSamplingSiteStructure of parenchyma of lungTherapeuticTimeTissuesToxic effectToxicant exposureToxicologyUniversitiescell injurychemical threatchemoproteomicschlorine gasdata integrationdesignexperiencefunctional losslung injurymultidisciplinaryoccupational hazardoxidationprotein complexprotein functiontherapeutic developmenttherapeutic targettoxicant
项目摘要
Project Summary:
Phosgene and chlorine are two toxic gases produced on large industrial scales that pose occupational hazards
and chemical threats to the public and military. Both toxicants modify proteins in various ways and induce
oxidative stress in the lung which perturb critical functions and pathways. However, the precise nature and
sites of these modifications in the lung proteome have not been identified, and the potential chemical diversity
of these modifications poses an analytical challenge to unraveling the molecular mechanisms by which
chlorine and phosgene induce acute lung injury. This lack of biomolecular characterization of phosgene- and
chlorine-induced modification of protein targets has consequently hindered our ability to develop effective
countermeasures; there are currently no approved therapeutics for treating phosgene or chlorine gas
exposures. We propose to use chemoproteomic profiling—a subset of mass spectrometry-based proteomics
that can detect the sites and types of distinct chemical modifications to proteins—to comprehensively identify
specific proteins in the lung that have been chemically altered by phosgene and chlorine and perform pathway
analysis to identify protein candidates for future targeted countermeasure development.
The specific aims of this proposal are:
Aim 1: Dynamic redox profiling to identify the temporal protein cysteine oxidation events and global proteome
changes following gaseous toxicant exposure
Aim 2: Mapping phosgene- and chlorine-induced protein modifications in the lung using electrophilic chemical
probes
Aim 3: Data integration and network analysis to identify shared and unique molecular targets of phosgene and
chlorine for therapeutic development
项目总结:
光气和氯是大规模工业生产中产生的两种有毒气体,会造成职业危害。
以及对公众和军方的化学威胁。这两种毒物都以不同的方式修饰蛋白质并诱导
肺部的氧化应激,它扰乱了关键的功能和途径。然而,准确的性质和
这些修饰在肺蛋白质组中的位置尚未确定,潜在的化学多样性
这些修饰对解开分子机制提出了分析挑战,通过这些机制
氯气和光气可致急性肺损伤。缺乏光气的生物分子特征--以及
因此,氯诱导的蛋白质靶标的修饰阻碍了我们开发有效的
对策:目前还没有获得批准的治疗光气或氯气的疗法
曝光。我们建议使用化学蛋白质组学--基于质谱学的蛋白质组学的子集
可以检测蛋白质的不同化学修饰的位置和类型-以全面识别
肺中被光气和氯化学改变的特定蛋白质和执行途径
分析以确定未来有针对性的对策开发的候选蛋白质。
这项建议的具体目标是:
目的1:动态氧化还原图谱以确定半胱氨酸氧化事件和全球蛋白质组
气态毒物暴露后的变化
目的2:用亲电化学方法定位光气和氯诱导的肺内蛋白质修饰
探头
目标3:数据集成和网络分析,以确定共享的和唯一的光气和
用于治疗开发的氯
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Satyanarayana Achanta其他文献
Satyanarayana Achanta的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Satyanarayana Achanta', 18)}}的其他基金
Pulmonary cell fate and lung repair in rodent and porcine models of chlorine and phosgene inhalation injuries
氯和光气吸入损伤的啮齿动物和猪模型中的肺细胞命运和肺修复
- 批准号:
10506127 - 财政年份:2022
- 资助金额:
$ 49.42万 - 项目类别:
Inhibition of soluble epoxide hydrolase protects against phosgene-induced lung injuries
抑制可溶性环氧化物水解酶可预防光气引起的肺损伤
- 批准号:
10464888 - 财政年份:2021
- 资助金额:
$ 49.42万 - 项目类别:
Inhibition of soluble epoxide hydrolase protects against phosgene-induced lung injuries
抑制可溶性环氧化物水解酶可预防光气引起的肺损伤
- 批准号:
10207055 - 财政年份:2021
- 资助金额:
$ 49.42万 - 项目类别:
Specialized pro-resolving mediators as potential medical countermeasures in a pig model of chlorine gas-induced acute lung injury
专门的促解决介质作为氯气引起的急性肺损伤猪模型的潜在医学对策
- 批准号:
10153787 - 财政年份:2020
- 资助金额:
$ 49.42万 - 项目类别:
Advanced TRPA1 Inhibitor for the Treatment of Chlorine Inhalation Injury
用于治疗氯吸入损伤的先进 TRPA1 抑制剂
- 批准号:
10247523 - 财政年份:2019
- 资助金额:
$ 49.42万 - 项目类别:
Advanced TRPA1 Inhibitor for the Treatment of Chlorine Inhalation Injury
用于治疗氯吸入损伤的先进 TRPA1 抑制剂
- 批准号:
10002221 - 财政年份:2019
- 资助金额:
$ 49.42万 - 项目类别:
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 49.42万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 49.42万 - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
$ 49.42万 - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
$ 49.42万 - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
$ 49.42万 - 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
- 批准号:
23K07651 - 财政年份:2023
- 资助金额:
$ 49.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
$ 49.42万 - 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
- 批准号:
10575258 - 财政年份:2023
- 资助金额:
$ 49.42万 - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
$ 49.42万 - 项目类别:
Roles of N-glycans on neutrophil beta2 integrins in progression of acute lung injury
N-聚糖对中性粒细胞β2整合素在急性肺损伤进展中的作用
- 批准号:
10837431 - 财政年份:2023
- 资助金额:
$ 49.42万 - 项目类别: